Trial Profile
The physiology of glucagon-like peptide-1 receptor expression in patients with endogenous hyperinsulinism: correlation with histopathology
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Hyperinsulinaemia
- Focus Pharmacodynamics
- 27 Nov 2015 New trial record